Fingerprint
Dive into the research topics of 'Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically